Stellar Biotechnologies, Inc. (41) | Business Finance (16)

Browse by Subcategory

Recent Contracts

Form of Pre-Funded Warrant (Filed With SEC on March 23, 2022)
Form of Securities Purchase Agreement, dated March 21, 2022, by and between the Company and the Purchaser (Filed With SEC on March 23, 2022)
First Amendment to Equity Distribution Agreement, dated as of March 4, 2022, by and between Edesa Biotech, Inc. and RBC Capital Markets, LLC (Filed With SEC on March 4, 2022)
Underwriting Agreement (Filed With SEC on February 26, 2021)
Form of Subscription Agreement between Edesa Biotech, Inc. and certain investors (Filed With SEC on January 6, 2020)
Share Exchange Agreement, dated as of March 7, 2019, by and between Stellar Biotechnologies Inc., Edesa Biotech Inc. and the Edesa Shareholders (Filed With SEC on March 8, 2019)
Form of Private Placement Warrant (Filed With SEC on March 23, 2022)
Form of Placement Agent Warrant (Filed With SEC on March 23, 2022)
Equity Distribution Agreement, dated as of November 22, 2021, by and between Edesa Biotech, Inc. and RBC Capital Markets, LLC (Filed With SEC on November 22, 2021)
Form of Underwriter Warrant (Filed With SEC on February 26, 2021)
Equity Distribution Agreement, dated as of September 28, 2020, by and between Edesa Biotech, Inc. and RBC Capital Markets, LLC (Filed With SEC on September 28, 2020)
Securities Purchase Agreement by and between Edesa Biotech, Inc. and NovImmune SA dated April 17, 2020 (Filed With SEC on April 23, 2020)
Purchase Agreement by and between Edesa Biotech Research, Inc. and NovImmune SA dated April 17, 2020 (Filed With SEC on April 23, 2020)
Form of Class A Purchase Warrant to be issued to investors (Filed With SEC on January 6, 2020)
Form of Class B Purchase Warrant to be issued to investors (Filed With SEC on January 6, 2020)
Form of Warrant to be issued to Brookline Capital Markets, a division of Arcadia Securities, LLC (Filed With SEC on January 6, 2020)